Workgroup III : Diagnosis and management of lymphedema (pages 2882–2885)
Stanley G. Rockson, Linda T. Miller, Ruby Senie, Michael J. Brennan, Judith R. Casley-Smith, Ethel Földi, Michael Földi, Gail L. Gamble, Renato G. Kasseroller, Albert Leduc, Robert Lerner, Peter S. Mortimer, Sandra A. Norman, Chester L. Plotkin, Margaret E. Rinehart-Ayres and Arnold L. Walder
Version of Record online: 9 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19981215)83:12B+<2882::AID-CNCR45>3.0.CO;2-0
The purpose of this workshop was to derive a consensus statement regarding the diagnosis and treatment of lymphedema following breast carcinoma therapy. There was consensus on the importance of the patient's subjective presentation with early changes; the importance of early management of patients during the first months after breast carcinoma therapy; and the importance of a multidisciplinary approach to the therapy of lymphedema, with differentiation among those modalities that achieve volume reduction of the involved limb from those that maintain long term beneficial therapeutic effects.